Wen Song Tan
Director/Board Member at Tasly Biopharmaceuticals Co., Ltd.
Profile
Wen Song Tan is an Independent Non-Executive Director at Tasly Biopharmaceuticals Co., Ltd.
and VP-Cell Engineering & Transgenic Organism Branch at Chinese Society For Cell Biology.
He was the Director-Higher Education at East China University of Science & Technology from 2009 to 2015 and a Member-Tissue Engineering & Regenerative Medicine at Chinese Society of Biomedical Engineering from 2013 to 2017.
Dr. Tan earned his doctorate degree from East China University of Science & Technology in 1993.
Wen Song Tan active positions
| Companies | Position | Start |
|---|---|---|
Tasly Biopharmaceuticals Co., Ltd.
 Tasly Biopharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Tasly Biopharmaceuticals Co., Ltd. is a biopharmaceutical company, which engages in research & development, manufacturing, sales and marketing of proprietary biological products. It focuses on therapeutic areas of cardiovascular diseases, oncology and autoimmune, and alimentary tract and metabolism. The company was founded by Lv Xinbo on October 29, 2001 and is headquartered in Shanghai, China. | Director/Board Member | 15/04/2019 |
| Chinese Society For Cell Biology | Corporate Officer/Principal | 01/10/2016 |
Former positions of Wen Song Tan
| Companies | Position | End |
|---|---|---|
| Chinese Society of Biomedical Engineering | Corporate Officer/Principal | 01/04/2017 |
| East China University of Science & Technology | Corporate Officer/Principal | 01/12/2015 |
Training of Wen Song Tan
| East China University of Science & Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Tasly Biopharmaceuticals Co., Ltd.
Tasly Biopharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Tasly Biopharmaceuticals Co., Ltd. is a biopharmaceutical company, which engages in research & development, manufacturing, sales and marketing of proprietary biological products. It focuses on therapeutic areas of cardiovascular diseases, oncology and autoimmune, and alimentary tract and metabolism. The company was founded by Lv Xinbo on October 29, 2001 and is headquartered in Shanghai, China. | Health Technology |
| Chinese Society For Cell Biology | |
| Chinese Society of Biomedical Engineering |
- Stock Market
- Insiders
- Wen Song Tan
